The two companies will test-run iCLUE & ASK, a target discovery service. When searching for diseases under research, AI algorithms recommend candidates for "targets," which are the cause of disease. SK C&C said in a statement that a large amount of knowledge is visualized and presented in the form of a network graph along with recommended evidence information.
The service can reduce time and money in the process of searching and analyzing disease and drug information. Standigm removes the traditional guesswork from data analysis by using AI, automatically examining whole biomedical databases to learn what is hiding just out of sight. In December 2019, the startup partnered with CJ HealthCare, a bio company, to develop innovative anti-cancer drug candidates.
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.